Indications -Therapeutic Areas

  • Clinical study with medical device for the treatment of Meibomian gland (2006)

  • A Multi-center, Double-Masked, Parallel Group, Placebo-Controlled Study to Assess the Efficacy and Safety of the medicine as Therapy in Subjects with Active Noninfectious Intermediate, Posterior or Pan-uveitis (2011)

  • A prospective, randomized, double-masked, placebo controlled clinical trial to investigate the efficacy of the IMP on intraocular pressure (IOP) and bleb formation after glaucoma filtering surgery in adults (2012)

  • A Randomised, Double-Blind, Parallel-Group, Placebo Controlled PoC Study to Assess the Efficacy, Safety, Tolerability and Pharmacokinetics of study drug in Subjects with First Episode of Acute Optic Neuritis (AON) (2014)

  • A Phase I/II, Prospective, Randomized, Parallel Group, Single-Masked, Multicenter Study of the Safety and Efficacy of Single Dose Suprachoroidal Investigational Medicinal Product (IMP) in Patients with Refractory Macular Edema (2015)/span>

  • Randomized controlled clinical study with medical device for monitoring eye strain (2011-2012)

  • A single-center, randomized, double blinded, prospective study to assess the changes in the 24-hour IOP pattern in relation to the medical device in healthy subjects (2013-2014)

  • A single-center, open label, prospective study assessing the intraocular pressure patterns using a medical device in association with a medical injection (2014)

  • Clinical trial phase IV-II, proof of concept, randomized, controlled trial with sham treatment, double-blind, single-center, with two parallel groups to assess the efficacy and safety intravitreal of the investigation product in improving visual acuity in patients with Age-related macular degeneration (2014)

  • International post marketing clinical follow-up investigation to evaluate the clinical results of treatment with bilaterally implanted medical device in cataract patients using laser assisted capsulotomy (2015)